1. Guidance for Industry: S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use;USFDA,2012
2. M7 guideline: Assessment and control of DNA reactive (Mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk;ICH,2017
3. Q3A (R2): impurities in new drug substances.;ICH,2006
4. Martindale, The Complete Drug Reference;Reynolds,1999
5. Cinnarizine: a contemporary review;Kirtane;Ind J Otolaryngol Head Neck Surg,2019